pradaxa bleeding risk

New Patient Registry Will Track Safety of Pradaxa, Other Antithrombolic Treatments

by NadrichCohenLLP May 3, 2012 Personal Injury

Boehringer Ingelheim, maker of the increasingly popular anticoagulant drug Pradaxa, has announced that it will establish a new patient registry which will allow the company to track the safety of Pradaxa for patients suffering from a heart rhythm condition known as atrial fibrillation (AF). The GLORIA(TM)-AF Registry is expected to be completed in 2020 and […]

Read the full blawg post →

FDA Report Suggests Higher Number of Pradaxa Bleeding Deaths in 2011

by NadrichCohenLLP April 14, 2012 Personal Injury

The blood-thinning drug Pradaxa (dabigatran) has been linked to a number of serious complications, including an increased risk of serious and in some cases, fatal, bleeding events. Boehringer Ingelheim, the company that manufactures Pradaxa, acknowledged in November 2011 that the drug was responsible for approximatley 260 deaths worldwide. A new report issued by the Food […]

Read the full blawg post →

U.K. Health Agency Backs Pradaxa, Despite Bleeding Risk

by NadrichCohenLLP March 16, 2012 Personal Injury

The U.K.’s top medical-cost regulator is putting its support behind Pradaxa for the prevention of blood clots in patients who suffer from a heart rhythm condition known as atrial fibrillation (AF). The announcement comes as concerns continue to mount over the safety of Pradaxa, which has been linked to numerous serious and in some cases, […]

Read the full blawg post →